How to buy Zimmer Biomet (ZBH) shares in the UK

Learn how to easily invest in Zimmer Biomet shares.

Zimmer Biomet Holdings Inc (ZBH) is a publicly traded medical devices business based in the US. It opened the day at $150.39 after a previous close of $150.4. During the day the price has varied from a low of $149.185 to a high of $151.725. The latest price was $151.23 (25 minute delay). Zimmer Biomet is listed on the NYSE and employs 19,500 staff. All prices are listed in US Dollars.

How to buy shares in Zimmer Biomet

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: ZBH in this case.
  5. Research Zimmer Biomet shares. The platform should provide the latest information available.
  6. Buy your Zimmer Biomet shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Fees for buying 5x Zimmer Biomet shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $10 £3.33
£669.20 total
Capital at risk
IG Share Dealing logo £0 £250 £12.18
£678.05 total
Capital at risk
Fineco logo £0 No minimum £6.66
£672.52 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £18.61
£684.47 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £0.67
£666.53 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £17.98
£683.84 total
Capital at risk
Stake logo £0 £50 £3.33
£669.20 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £17.82
£683.69 total
Capital at risk

Full comparison of share dealing platforms

Zimmer Biomet share price (NYSE:ZBH)

Use our graph to track the performance of ZBH stocks over time.

Zimmer Biomet price performance over time

Historical closes compared with the last close of $151.23

1 week (2022-09-27) 44.28%
1 month (2022-09-02) 43.25%
3 months (2022-07-01) 40.98%
6 months (2022-04-01) 18.40%
1 year (2021-10-04) 6.16%
2 years (2020-10-02) 13.13%
3 years (2019-10-04) 15.85%
5 years (2017-10-04) 36.72%

Is it a good time to buy Zimmer Biomet stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.

Promoted
eToro Free Stocks

Invest in Zimmer Biomet shares with 0% commission

  • Start investing from as little as $10
  • Pay no stamp duty on UK shares
  • Join 25 million users who trust their investments with eToro
Other fees apply. Capital at risk

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is Zimmer Biomet under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

P/E ratio

Zimmer Biomet's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 76x. In other words, Zimmer Biomet shares trade at around 76x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

PEG ratio

Zimmer Biomet's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.1452. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Zimmer Biomet's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

EBITDA

Zimmer Biomet's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $2.4 billion (£2.1 billion).

The EBITDA is a measure of a Zimmer Biomet's overall financial performance and is widely used to measure a its profitability.

Environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Zimmer Biomet.

Total ESG risk score

Zimmer Biomet's total ESG risk: 40.16

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Zimmer Biomet's overall score of 40.16 (as at 01/01/2019) is pretty weak – landing it in it in the 77th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Zimmer Biomet is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Environmental score

Zimmer Biomet's environmental score: 9.29/100

Zimmer Biomet's environmental score of 9.29 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Zimmer Biomet is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Social score

Zimmer Biomet's social score: 23.4/100

Zimmer Biomet's social score of 23.4 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Zimmer Biomet is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Governance score

Zimmer Biomet's governance score: 16.46/100

Zimmer Biomet's governance score puts it squarely in the 9th percentile of companies rated in the same sector. That could suggest that Zimmer Biomet is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Controversy score

Zimmer Biomet's controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Zimmer Biomet scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Zimmer Biomet has, for the most part, managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Zimmer Biomet Holdings Inc was last rated for ESG on: 2019-01-01.

Total ESG score 40.16
Total ESG percentile 77.24
Environmental score 9.29
Environmental score percentile 9
Social score 23.4
Social score percentile 9
Governance score 16.46
Governance score percentile 9
Level of controversy 2

Zimmer Biomet shares at a glance

Information last updated 2021-09-24.
Open$150.39
High$151.725
Low$149.185
Close$151.23
Previous close$150.4
Change$0.83
Change %0.5519%
Volume1,657,789
Information last updated 2022-10-02.
52-week range$100.1659 - $141.7222
50-day moving average$111.0182
200-day moving average$116.5173
Wall St. target price$127
PE ratio75.7609
Dividend yield$0.96 (0.92%)
Earnings per share (TTM)$1.38

Do Zimmer Biomet shares pay dividends?

0.9%

Dividend yield: 0.92% of stock value

0.9%

Forward annual dividend yield: 0.92% of stock value

13.3%

Dividend payout ratio: 13.25% of net profits

Zimmer Biomet has recently paid out dividends equivalent to 0.92% of its share value annually.

Zimmer Biomet has paid out, on average, around 13.25% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.92% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 0.92% return on their shares, in the form of dividend payments. In Zimmer Biomet's case, that would currently equate to about $0.96 per share.

While Zimmer Biomet's payout ratio might seem low, this can signify that the company is investing more in its future growth.

Zimmer Biomet's most recent dividend payout was on 31 October 2022. The latest dividend was paid out to all shareholders who bought their shares by 29 September 2022 (the "ex-dividend date").

Share price volatility

Over the last 12 months, Zimmer Biomet's shares have ranged in value from as little as $100.1659 up to $141.7222. A popular way to gauge a stock's volatility is its "beta".

ZBH.US volatility(beta: 1.14)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Zimmer Biomet's is 1.1402. This would suggest that Zimmer Biomet's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site